Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive Drugs: A Meta-Analysis

By Van Bortel Luc M.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 35-44

Adis International

Access to resources Recommend Favorite

Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis

By Caldeira Daniel   David Cláudio   Sampaio Cristina  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 263-277

Adis International

Access to resources Recommend Favorite

Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting: Olmesartan Medoxomil Compared with Losartan, Valsartan, and Irbesartan

By Simons W.R.  

PharmacoEconomics, Vol. 21, Iss. 1, 2003-01 ,pp. : 61-74

Adis International

Access to resources Recommend Favorite

Neointimal Hyperplasia Inhibition Effect of Angiotensin II Type 1 Receptor Blockers in Patients after Coronary Stent Implantation: A Meta-Analysis

By Kun Xie   Yong Li   Bo Jin   Hai-Ming Shi  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 209-213

Adis International

Access to resources Recommend Favorite

Dose-Response Characteristics of Olmesartan Medoxomil and Other Angiotensin Receptor Antagonists

By Smith David H.G.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite